Risk of Recurrent Stroke in Patients with Sickle Cell Disease Treated with Erythrocyte Transfusions
J Pediatr 126:896-899, Pegelow,C.H.,et al, 1995
Controlled Trial of Transfusions for Silent Cerebral Infarcts in Sickle Cell Anemia
NEJM 371:699-710, DeBaun, M.R.,et al, 2014
Postcontrast FLAIR MRI Demonstrates Blood-Brain Barrier Dysfunction in PRES
Neurol 72:760-762, Weier,K.,et al, 2009
Clinical Presentation and Pre-Mortem Diagnosis of Variant Creutzfeldt-Jakob Disease Associated With Blood Transfusion: A Case Report
Lancet 368:2061-2067, Wroe,S.J.,et al, 2006
Discontinuing Prophylactic Transfusions Used to Preven Stroke in Sickle Cell Disease
NEJM 353:2769-2778,2743, The Optimizing Primary Stroke Prevention in Sickle Cell Anemia (STOP 2) Trial Investigators, 2005
Safety of Tissue Plasminogen Activator for Acute Stroke in Menstruating Women
Stroke 33;2506-2508, Wein,T.H.,et al, 2002
Silent Infarcts in Children With Sickle Cell Anemia and Abnormal Cerebral Artery Velocity
Arch Neurol 58:2017-2021, Pegelow,C.H.,et al, 2001
Prevent of a 1st Stroke by Transfusions in Children/Sickle Cell Anemia & Abnorm Results on Transcr Doppler Ultrasonog
NEJM 339:5-11, Adams,R.J.,et al, 1998
Discontinuation of Long-Term Transfusion Therapy in Patients with Sickle Cell Disease & Stroke
J Pediatr 131:757-760, Rana,S.,et al, 1997
The Use of Transcranial Ultrasonography to Predict Stroke in Sickle Cell Disease
NEJM 326:605-610, 6371992., Adams,R.,et al, 1992
Neurologic Events after Partial Exchange Transfusion for Priapism in Sickle Cell Disease
J Pediatr 120:882-885, Rackoff,W.R.,et al, 1992
High Risk of Recurrent Stroke after Discont of 5 to 12 Yrs of Transfusions in Sickle Cell Disease
J Pediatr 118:377-379, Wang,W.C.,et al, 1991
Vision and Hearing During Deferoxamine Therapy
J Pediatr 117:326-330, Cohen,A.,et al, 1990